Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · agilon health, inc. (AGL)

agilon health Q3 revenue rises 6% to $1.52 billion; raises 2026 Adjusted EBITDA guidance

Positive Impact 4 of 5 guidance Written later

agilon health reported third quarter 2026 revenue of $1.52 billion, up 6% from a year earlier, and net income of $35 million compared with a net loss of $110 million in the third quarter of 2025. The company raised its full-year 2026 Adjusted EBITDA guidance to $145 million to $155 million from $75 million to $95 million, but total members on its platform fell 8% year over year to 566,000.

Key points

  • Third quarter revenue was $1.52 billion, up 6% from $1.44 billion in the third quarter of 2025.
  • Net income was $35 million, or $1.97 per diluted share, versus a net loss of $110 million, or $6.65 per share, a year earlier.
  • Full-year 2026 Adjusted EBITDA guidance was raised to $145 million to $155 million from $75 million to $95 million.
  • Total members live on the platform were 566,000 as of September 30, 2026, down from 618,000.

The filing

Companyagilon health, inc. (AGL)
Form8-K, current report
Filed with the SECNov 4, 2026, 4:07 PM ET
Accession number0001628280-26-070132

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.